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Using DNA sequences 59 to open reading frames, we have constructed green fluorescent protein (GFP) fusions and
generated spatial and temporal tissue expression profiles for 1,886 specific genes in the nematode Caenorhabditis
elegans. This effort encompasses about 10% of all genes identified in this organism. GFP-expressing wild-type animals
were analyzed at each stage of development from embryo to adult. We have identified 59 DNA regions regulating
expression at all developmental stages and in 38 different cell and tissue types in this organism. Among the regulatory
regions identified are sequences that regulate expression in all cells, in specific tissues, in combinations of tissues, and
in single cells. Most of the genes we have examined in C. elegans have human orthologs. All the images and expression
pattern data generated by this project are available at WormAtlas (http://gfpweb.aecom.yu.edu/index) and through
WormBase (http://www.wormbase.org).
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Introduction
Determining when and where genes are expressed is often
key to determining their function. Although expression
proﬁling of genes using Serial Analysis of Gene Expression
(SAGE) and microarrays is now routine, we still have
complete developmental expression proﬁles for only a small
fraction of all genes expressed in any metazoan. The spatial
resolution of these two techniques is limited unless puriﬁed
cell populations can be isolated in sufﬁcient abundance to
provide the necessary RNA (for examples, see [1–3]). How
then do we gain expression information on the thousands of
human genes that are still largely uncharacterized? One
approach is to use high-throughput RNA in situ hybridization
as has recently been done for brain tissue in the mouse [4]. In
this study, 20,000 genes were assayed in the adult male mouse
brain, and their distribution in many cases was resolved to the
level of a single cell. Another complementary approach
involves employing green ﬂuorescent protein (GFP) [5] as a
marker to monitor gene expression in a speciﬁc cell or tissue.
The GenSAT project [6] uses Bacterial Artiﬁcial Chromo-
somes (BACs) with GFP-marked genes in transgenic mice to
monitor tissue and cell expression. About 2,000 gene
expression patterns are described at the GenSAT site
(http://www.gensat.org/). Because gene functions were largely
maintained during evolution, yet another possible approach
is to ﬁrst study orthologs of these genes in less complex
organisms. Knowing what tissue or cell type expresses a
particular gene in a simpler system such as Caenorhabditis
elegans or Drosophila melanogaster could help drive the analysis
of this gene in a more complex tissue or organ system, as is
found in mice and humans. In Drosophila, a large-scale in situ
hybridization study has now documented the expression
pattern of close to 3,000 genes in the developing embryo ([7];
http://www.fruitﬂy.org/cgi-bin/ex/insitu.pl). The goal of our
study was to characterize the temporal and spatial expression
pattern of human orthologs in the nematode C. elegans down
to the resolution of a single cell. Speciﬁcally, we determined
the expression proﬁle of individual genes throughout the
whole organism and across all life stages. Independent of the
biomedical aspects of our approach, the analysis of complex
expression patterns of many genes may not only facilitate
functional analysis in C. elegans and other organisms, but also
create a foundation for decoding the informational hierar-
chies governing gene expression.
C. elegans has several advantages as a venue for expression
studies at this resolution. The main advantages are that it is
one of the simplest multicellular organisms with a complete
genome sequence available [8] and a completely documented
cell lineage [9,10]. In addition, the small size, transparency,
and limited cell number of the worm allow for the easy
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PLoS BIOLOGYobservation of many complex cellular and developmental
processes that are difﬁcult to observe in higher eukaryotes,
and morphogenesis can be observed at the level of a single
cell [11].
Besides ourselves, only two groups have attempted large-
scale expression proﬁling in C. elegans at this resolution. Hope
and colleagues in the past have used lacZ reporters and
currently are using the newly developed ‘‘promoterome’’ to
characterize gene expression [12–14]. Another approach,
developed by Yuji Kohara’s group in Japan, uses in situ
hybridization to ﬁxed animals at different developmental
stages (http://nematode.lab.nig.ac.jp). Our approach was to
examine expression in living animals transformed with GFP
fused to DNA 59 of genes with human orthologs. For gene
fusion and ampliﬁcation, we used ‘‘PCR stitching’’ [15], which
proved to be a fast, efﬁcient, and economical method for
obtaining such constructs, and we have demonstrated that the
method is scalable [1]. Because of the relatively small
intergenic regions in the C. elegans genome, typically less
than 3 kb, PCR stitching did not have to be done over large
intervals. These small intergenic intervals illustrate yet
another advantage of doing this type of study in the
nematode. This is a key advantage that sets our project apart
from previous high-throughput expression projects done in
other organisms. Our overall approach takes advantage of the
transparency of the nematode and allows us to visualize gene
expression in vivo, in real time, in a living animal. This
method allowed us to determine the temporal and spatial
distribution of the expressed GFP in close to 10% (1,886) of
all genes identiﬁed in this organism.
Results
Determining the Temporal and Spatial Expression of C.
elegans Genes
Expression patterns analyzed for the 1,886 genes in this
study were primarily, but not exclusively, from nematode
orthologs of human genes (.80%). Our target genes were
drawn from nematode–human ortholog groups in the
InParanoid database [16] (http://inparanoid.sbc.su.se), select-
ing primarily genes for which no function is known. To
analyze the in vivo spatial and temporal expression proﬁles of
thousands of genes, we needed a high-throughput approach
for GFP fusion constructs. GFP has been shown to be an
effective cell marker in C. elegans [5,17], and because of the
need for cost-effectiveness and scalability, we chose to use the
promotor::GFP fusion technique ‘‘PCR stitching’’ [15]. The 59
regulatory regions examined in this study extend a maximum
of 3 kb upstream of the predicted ATG initiator site for a
targeted gene. Most often, an upstream gene was nearer than
3 kb and we did not extend our analysis into or past this
adjacent gene. As a benchmark and internal control, 10% of
our analysis included genes with expression annotation in
WormBase. We used half of these benchmark genes and
found that 80% of our observations on expression matched
the annotated expression patterns. For another 10% of the
benchmark genes, we found some overlap, and for about
10%, we found little or no agreement with expression
patterns compiled at WormBase. (Table S1).
Transformants carrying GFP fusions were subject to
detailed in vivo analysis as outlined in Figure 1. We have
observed GFP expression for 1,886 genes. Because we only
Figure 1. Analysis Pipeline for GFP Expressing Strains
Strains with nonubiquitous embryonic expression prior to 2-fold stage
were stabilized for 4-D analysis, and all postembryonic strains were
briefly assessed for their expression pattern complexity and then
assigned to either the confocal microscope or the stereomicroscope
for detailed observations. Once the expression analysis was complete,
the data were sent to the public domain, and the strains were sent to the
CGC (Caenorhabditis Genetics Center).
doi:10.1371/journal.pbio.0050237.g001
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Author Summary
Knowing where a protein is expressed provides an important clue
about its potential function. As critical as this information is, we have
complete developmental expression profiles for only a small fraction
of all genes expressed in any metazoan. Here, we have generated
spatial and temporal tissue expression profiles for 10% of all genes
in the nematode Caenorhabditis elegans. Worms expressing putative
gene regulatory elements fused with green fluorescent protein were
analyzed at each stage of development from embryo to adult.
Among the regulatory regions identified are sequences that
regulate expression in all cells, in specific tissues, in combinations
of tissues, and in single cells. Most of the genes we have examined
in C. elegans have human orthologs. Our analysis of complex
expression patterns for so many genes may not only facilitate
functional analysis in C. elegans, but also create a foundation for
decoding the informational hierarchies governing gene expression
in all organisms.sampled 10% of the genes in this organism, we wanted to
ensure that speciﬁc functional categories were not over-
represented in our dataset. We used Gene Ontology (GO)
annotation to examine the genes in our set relative to the
whole genome and found that the representation of most
functional groups reﬂected their frequency within the
genome (Figure S1). Besides the genes for which we detected
expression, there were another 516 genes for which we did
not detect any expression (see Discussion). At present, only
15% of the strains exhibiting expression are in stable strains
(possibly chromosomal integrants). As is usual for micro-
injected transgenes, most strains carry unincorporated
concatamer arrays, and we detected mosaicism in many of
these strains. To compensate for this mosaicism, and to
ensure that we did not miss expressing cells, at least 20
replicates were analyzed for each developmental stage. Only
GFP-expressing cells and tissues that showed consistent
expression in 50% of the animals at any given developmental
stage were recorded.
Two subclasses of expressing strains were further analyzed:
(1) those with rare or complex expression patterns and (2)
those that showed embryonic expression before the comma
stage of embryogenesis. In the former case, the strains
underwent their ﬁnal analysis via 2-D and 3-D imaging on a
confocal microscope before being submitted to the public
Web site. In the latter case, the embryonic strains were ﬁrst
integrated (see Materials and Methods) and then recorded
during development using a four-dimensional (4-D) micro-
scope system (multifocal, time-lapse video recording system)
developed for the purpose of tracking embryonic cell
identities and movements [18,19]. Since the cell lineage of
C. elegans is invariant [10], we could use these recordings in
conjunction with Simi BioCell software [19] to retrace the cell
lineages and determine the identity of the cells expressing
GFP. This has resulted in 95 embryonic recordings, two
examples of which are illustrated in Figure 2. In the ﬁrst,
pC45G9.13 (Figure 2A–2D), expression is initially detected in
three cells, ABprappppa, M5, and MSpapaapa, but later
expands to include several other cells. In the second example,
pZK637.11 (Figure 2E–2H), expression is detected early
during embryogenesis, and includes the AB and MS lineages.
At present, only a portion (10%) of the embryonic recordings
have been completely analyzed and the lineage of all GFP
expressing cells determined.
The data from this project are publicly available at
WormBase and interactively at WormAtlas (http://gfpweb.
aecom.yu.edu/index). All strains are available from the
Caenorhabditis Genetics Center (http://www.cbs.umn.edu/CGC/
CGChomepage.htm) (currently, strain requests go through R.
Johnsen [bjohnsen@gene.mbb.sfu.ca]). Our Web site (http://
gfpweb.aecom.yu.edu/index) provides the user with two
formats for accessing the data: (1) a Browse page (Figure 3)
to display all strains and data, with a search option for stage
or tissue, and (2) a Gene Search page (Figure 4) that enables
the user to recover selected information on speciﬁc genes of
interest, or identify a subset of genes from the entire dataset
(e.g., show genes that are unc and have associated movies).
Each gene displayed has links through the gene name and
location to WormBase’s Gene Summary and mapping pages
(Figures 3C and 4C). The strain name has a link to a
comprehensive summary page containing all data relevant to
that strain (Figure 3D). Along with the data present on the
initial search readout page, other information included are
the primers used to amplify the promoter, whether the strain
is stabilized, and links to additional images of the strain.
GFP Expression Observed in Every Major Tissue and Cell
Type
A survey of temporal and spatial GFP expression patterns
for all 1,886 genes is shown in Table 1 and Figure 5, and some
illustrative examples in different tissues are displayed in
Figure 6. We have detected GFP at all developmental stages
and have identiﬁed expressed GFP in all major tissues except
the germinal gonad. Most GFP fusions express across all
developmental stages with 1,781 (95%) showing expression in
adults, 1,835 (97%) in larval animals, and 1,556 (83%)
expressing during embryogenesis. A majority of the 59
regulatory DNA sequences examined drive GFP expression
in the nervous system (63%), the intestine (63%), the pharynx
(40%), and the body-wall muscle (32%) (Table 1). Subsets of
cells and tissues within these broad categories are also
delineated; we have observed GFP expression speciﬁc to the
nerve ring, sensory neurons, ventral nerve cord, pharynx,
seam cells, the excretory canal and excretory gland cells, the
spermatheca, and coelomocytes, to list a few.
O v e rt h ec o u r s eo fo u ra n alysis, we observed GFP
expression in 38 tissues and cell types throughout all
developmental stages: embryo, larval (L1–L4) and adult
(Figure 6; Table 1). We observed many examples of temporal
expression stability and examples where the expression
pattern changed during development. For example,
pF26F4.6::GFP exhibited hypodermal expression during the
larval stages, but no GFP was detectable in adult hypodermis;
pY61A9LA.10::GFP showed intestinal and neural expression
during early developmental stages, whereas adults lacked any
GFP expression at all. Conversely, we observed cases where
GFP expression was turned on later in development, as in the
case of pF11F1.1::GFP, where no GFP was detected until the
animals matured to adults, at which point hypodermal and
intestinal expression were observed. Examples of changing
patterns of expression formed a minority of our dataset. This,
in some respects, was to be expected because we used the
enhanced form of GFP (EGFP), which has a long half-life.
Early expressed embryonic GFP could persist through the 14
h (22 8C) duration of embryogenesis [20] and possibly past
hatching. Similarly, GFP expressed during larval development
may persist in adult tissues. Also, embryonic expression was
never detected earlier than the 50–100 cell stage of embryo-
genesis, possibly a consequence of our inability to detect
maternal RNA contributions to the developing embryo [21]
(see Discussion).
Although the concatameric arrays may have led to germline
silencing in the gonad [21], they may also have contributed to
increasing the sensitivity of detecting an expression signal in
other tissues. As described in Materials and Methods, each
array has several copies of the fusion GFP construct. Several
of these GFP fusions can express simultaneously in a
particular cell. As a test of the sensitivity of GFP fusions, we
used them to see if we could detect expression from genes
with low numbers of SAGE tags. Speciﬁcally, we were able to
detect a GFP signal for 232 genes that only had a single tag in
either the embryo or one of the following tissues: neurons,
hypodermis, intestine, or muscle. In each case, GFP expres-
sion was detected in the tissue for which only a single SAGE
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Gene Expression in C. eleganstag had been recorded (Table S2). The SAGE data can be
viewed at http://tock.bcgsc.ca/cgi-bin/sage170 and WormBase.
The source of this material is from different developmental
stages and different puriﬁed tissue and cell populations
during early development ([1] and unpublished data).
To measure the reliability and accuracy of the reporter
expression patterns described in this study, we took further
advantage of the existing SAGE data for speciﬁc tissues. We
have compared the intersects between our GFP expression
patterns for muscle, gut, and the nervous system against
SAGE data for stage-speciﬁc puriﬁed cells populations for
each of these tissues. In each case, we can identify about 70%
of GFP reporter genes in the corresponding SAGE library
(e.g., genes for 71% of GFP reporters expressed in muscle are
Figure 3. The Browse Page
The Browse page initially lists all genes (B) with the relevant information as text or links, but is searchable (A) by developmental stage or a specific tissue.
The links lead to (C) the Wormbase Gene Summary, (D) a comprehensive summary page specific to that strain, and (E) the Wormbase location map.
doi:10.1371/journal.pbio.0050237.g003
Figure 2. Embryonic Cell Lineages of C45G9.13 and ZK637.11
(A) and (E) display the embryonic cell lineages of C45G9.13 and ZK637.11, respectively.
(B) and (C) are Nomarski differential contrast microscopy images of C45G9.13 with a GFP overlap. The view is from the ventral side with anterior to the
left of the image. The highlighted cells are a, ABprappppa; b, M5; and c, Mspapaapa.
(F) and (G) show Nomarski images of ZK637.11 with ventral to the bottom and anterior to the left. The cells marked in (G) are a, ABprppa; b, ABprpap; c,
MSppa; d, MSpaa; e, ABalaap; f, ABalpaa; g, ABalapp; h, ABalppa; I, ABplaap; and j, ABplapp.
(D) and (H) are 3-D stick and ball models of the nuclei of the expressing cells of C45G9.13 and ZK637.11, respectively. In both panels, anterior is to the
left and ventral is on the bottom. In (D), the orange ball represents M5: note that the embryo has been rotated 908 to the right compared to the above
Nomarski image. In (H), the orange ball corresponds to ABalapp.
doi:10.1371/journal.pbio.0050237.g002
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Gene Expression in C. elegansFigure 4. The Gene Search Page and Search Results
The Search page (A) and (B) allows the user to search the dataset with a combination of gene names and data types. The user can enter (A) specific
gene names or use an asterisk (*) to represent all genes and then choose (B) the list of data types representing specific information about the gene(s) of
interest. The logic for the Field column is OR, and the results (C) will display columns for the data types. The Refine Search column (B) operates under
AND logic for the selected field, and OR logic between fields, e.g., selecting ‘‘stable’’ transgene and ‘‘yes’’ Images will output all genes that are either
stable or have an associated image. Thus the genes displayed are limited only to those that evaluate to True for a selected field.
doi:10.1371/journal.pbio.0050237.g004
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Gene Expression in C. elegansdetected in the muscle SAGE library; unpublished data).
Considering that the SAGE libraries are limited to embryonic
tissue only and that half of the SAGE tags are present in single
copies, we believe this is a reasonable validation of the GFP
reporter expression patterns observed.
Most 59 Regulatory Sequences Drive Expression in
Multiple Tissues
Of the 1,886 genes with analyzable expression, only one in
ﬁve was found to be tissue speciﬁc and only a very few were
found to be cell speciﬁc (Figure 5; Table 1). Cell-speciﬁc
promoters were found in a few special cases, as in the
excretory cell in which we identiﬁed six 59 regulatory regions
that drove expression in only this cell (Figure 5). In another
example, we found four speciﬁc cases of 59 sequences limiting
expression to the head mesodermal cell (Figure 5). In this
study, we did not ﬁnd any examples where individual cells
belonging to a larger tissue group such as body-wall muscle,
or hypodermis, or the intestine expressed by themselves.
Tissue-speciﬁc GFP expression accounted for 20% of our
samples, and all major tissues in this organism are repre-
sented in our dataset (Figure 6; Table 1). Of the 414 tissue-
speciﬁc regulatory regions identiﬁed, the majority are
expressed exclusively either in neural (l55; Figure 7 displays
several examples of the complexity of the nervous system) or
intestinal tissue (136). Other tissues or cell groupings that
exhibited exclusive expression include the pharynx (40),
body-wall muscle (18), reproductive system (14), hypodermis
(10), hypodermal seam cells (8), pharyngeal gland cells (4), and
the arcade cells (2).
When we examine the remaining genes, we observe that
321 of these regulatory regions drive expression in only two
tissues. In the majority of these examples (72%), one of the
two tissues involved is neural. We detected no bias for speciﬁc
combinations of tissues or speciﬁc exclusions (Figure 8). Co-
expression in nerve and muscle (604 examples), nerve and
intestine (698 examples), or intestine and muscle (532
examples) are all roughly equivalent, with relatively little
contribution from hypodermal expression. Cell- and tissue-
speciﬁc regulatory regions clearly account for a minority of
our expression examples, because the majority of 59
regulatory regions we have analyzed, 1,151 (61%), drive
expression in several tissues. (This is reﬂected in the Venn
diagram of Figure 8 in which 493 examples express in at least
three of the tissues being examined). A portion of this last
group may represent ubiquitous expression, but it is not
always possible to conclude that every cell expresses GFP.
Widespread expression in an animal can make it extremely
difﬁcult to detect expression in each cell. In these cases,
mosaicism of expression, rather than a hindrance, can be
helpful. Figure 9 illustrates how mosaic expression can be
used to advantage to obtain images of structures within the
somatic gonad (Figure 9A, 9B, 9C, 9E, and 9G) and individual
cells of the gonad (Figure 9D, 9F, 9H, and 9I). All of the
examples in this ﬁgure are for genes that show expression in
many different cells and tissues (see database at http://gfpweb.
aecom.yu.edu/index for details on each gene.)
Using Expression Data to Mine for Minimal Promoters and
Conserved Motifs
A large source of regulatory sequences and expression data
permits investigation of regulatory sequences required to
drive expression in a speciﬁc cell or tissue type. We use
muscle as an example of how this dataset can be employed.
We ﬁrst identiﬁed several 59 sequences capable of driving
expression of GFP in body-wall muscle. We next took a subset
of these sequences (four) and mapped out the region
responsible for muscle expression by constructing a deletion
Table 1. Spatial and Temporal Expression of the 59 DNA::GFP
Fusions for the 1,886 Expressing Sequences
Tissue Larval Adult
Muscle Total 970 (41) 1,015 (86)
Pharyngeal muscle
a 74% (41) 71% (44)
Body wall muscle 66% (24) 63% (22)
Subset head muscle 16% (6) 15% (6)
Intestinal muscle 10% (6) 11% (22)
Anal depressor muscle 29% (7) 30% (30)
Anal sphincter 2% (1) 2% (0)
Uterine muscle — 7% (74)
Vulval muscle — 38% (388)
Hypodermal Total 558 (130) 453 (25)
Hypodermis 84% (107) 83% (14)
Seam cells 34% (37) 37% (15)
Intestinal Total 1,145 (179) 1,011 (45)
Subset intestine (ant/post) 4% (7) 7% (30)
Nervous system expression Total 1,146 (104) 1,072 (30)
Head ganglia 34% (16) 36% (4)
Ventral nerve cord 31% (25) 33% (20)
Head neurons 92% (104) 90% (18)
Amphids 12% (9) 12% (1)
Amphid socket cells 1% (5) 1% (0)
Labial sensilla 1% (0) 1% (0)
Mechanosensory neurons 2% (18) 2% (18)
Pharyngeal neurons 5% (3) 5% (2)
Body-length neurons
b 16% (10) 18% (20)
PVT interneuron 2% (3) 2% (0)
Tail neurons 53% (42) 55% (28)
Phasmids 8% (3) 8% (1)
Phasmid sheath cells .1% (0) .1% (0)
Glandular Total 242 (45) 205 (8)
Pharyngeal gland cells 25% (2) 29% (2)
Excretory gland cell 7% (1) 8% (1)
Rectal gland cells 74% (42) 69% (5)
Reproductive system Total 288 (62) 565 (339)
Distal tip cell 22% (22) 9% (9)
Developing gonad 9% (26) —
Developing vulva 75% (217) —
Developing uterus 18% (53) —
Uterus — 6%(33)
Uterine-seam cell 3% (2) 2% (8)
Vulva—other
c — 23% (130)
Spermatheca-uterine valve — 4% (23)
Spermatheca 19% (3) 35% (147)
Gonad sheath cells 12% (6) 17% (66)
Miscellaneous Arcade cells 30 (10) 20 (0)
Pharyngeal intestinal valve 74 (13) 63 (2)
Head mesodermal cell 42 (2) 44 (4)
Excretory cell 169 (7) 183 (21)
Coelomocytes 25 (2) 30 (7)
Rectal epithelial cells 115 (11) 107 (3)
Expression is given in total number of expressing 59 DNA sequences, or as a percentage of
the total, if the tissue is a subgroup of a larger category. A single 59 DNA sequence can be
represented in multiple tissues, but only once in a given tissue. The larval and adult
columns indicate the number of 59 DNA sequences that drove GFP expression in the
indicated tissue at that stage, whereas the values in parentheses indicate the number
specific to the developmental stage.
aMay include pharyngeal marginal cells.
bNeurons not specific to head or tail region, e.g., PVT interneuron and touch cells.
cAny nonmuscle vulval expression, e.g., vulval hypodermis.
doi:10.1371/journal.pbio.0050237.t001
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These deletion constructs determined the minimal 59 DNA
sequence required to drive muscle expression. The four gene
promoters analyzed in our study were those of F15G9.4a,
C34E10.6, T04A8.4, and T27A1.4 (Figure 10). From the
deletion series, we found that the minimal length required
for muscle expression varied between the promoters, the
longest being 326 bp (Figure 10B), whereas the shortest was
only 143 bp (Figure 10D). When compared to each other,
except for T27A1.5 which contains an E box consensus
sequence, the minimal promoters were found to contain
neither any shared motifs nor any of the previously identiﬁed
muscle motifs [22,23] (unpublished data).
Discussion
Within this database, there are representatives of many of
the expression patterns that are possible in this organism. We
have identiﬁed 59 DNA sequences that drive expression in
single cells, in single tissues, in multiple tissues, and in all
tissues. The dataset is large enough so that one can make
some general statements about patterns of expression in this
organism. One conclusion from these data is that expression
within only a single cell using extant 59 sequences is rare. The
examples that exist in our dataset are usually examples in
which a single cell is equivalent to a tissue, as in the case of
the excretory cell. However, tissue-speciﬁc 59 regulatory
regions are abundant. We found many examples of expres-
sion limited to a single tissue, and this included such tissues as
the intestine, muscle, and the nervous system, the primary
tissues arising from the three primordial germ layers, of
endoderm, mesoderm, and ectoderm (Figure 8). There are
also expression patterns that represent subsets of these
tissues and expression patterns that are speciﬁc to organs
or specialized groupings of cells within these broader tissue
categories, for example, expression in the pharynx, but not
other muscle, or expression in the amphids/phasmids, but not
other cells of the nervous system. We also identiﬁed 59
regulatory regions that are not limited to regulating
expression in a single tissue, but may include two or more
tissues and even cells from several tissues. We also identiﬁed
several 59 sequences that apparently permit ubiquitous
expression (at least 1%). Finally, we observed 516 59
regulatory regions that did not exhibit any detectable
expression. Although there are several trivial explanations
for why these regions do not promote expression, there is also
the possibility that these are conditional promoters. Several
laboratories have requested these strains to test for expres-
sion in different genetic (male vs. hermaphrodite) or
environmental backgrounds. So far, none have been shown
to be conditional promoters.
The paucity of 59 regulatory regions that drive expression
in a single cell is perhaps disappointing, but it should not be a
surprising result. At least one quarter of the genome is
expressed in any particular tissue or cell type ([1], unpub-
lished data; http://tock.bcgsc.ca/cgi-bin/sage170) which, as we
observed, suggests even tissue-speciﬁc control regions will be
relatively infrequent. To identify regulatory regions that
drive expression in only single cells in this organism may
require other approaches. In our experience, single unique
genes predominantly express in multiple cell types. One
possible way to identify cell-speciﬁc control elements may be
to focus attention on gene families or alternative splice forms
of a single gene. The seven transmembrane domain and
guanyl cyclase gene families of receptors are excellent
examples of gene families in which isoforms are speciﬁc for
separate sensory neurons [24,25]. In this study, we did not
focus on gene families, but it may be the approach one should
take if the objective is to identify cell-speciﬁc markers.
The database should not be viewed as the ﬁnal arbiter of
complete expression for any speciﬁc gene. As we have only
included DNA 59 of a particular ORF, we may not have the
complete ‘‘promoter’’ or all possible ‘‘enhancer’’ elements
that impinge on the regulation and expression of this gene
Figure 5. A Categorization by Tissue, Summarizing the Influence of the 389 59 DNA Sequences that Drive Expression in a Single Tissue or Cell Type
doi:10.1371/journal.pbio.0050237.g005
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Our analysis misses any downstream, intronic, or more than
3-kb upstream elements important for proper gene expres-
sion. Because of this, a gene’s complete expression pattern
may differ from that observed using our reporter constructs.
As well, 85% of the strains we examined had concatamer
arrays with multiple copies of the regulatory region of the
gene. This led to mosaic expression when the concatamer
was lost, which meant that we had to be sure to examine
several animals to ensure that we described all expression
patterns possible using this stretch of DNA as a control
element. Stably inherited constructs were made for about
15% of the samples, including those from which we desired
to make an embryo 4-D recording. Note that the afore-
mentioned caveats are not unusual, as most single gene
studies reported in most C. elegans publications work with
the same limitations (see expression report summaries in
WormBase). If one uses reproducibility as a benchmark,
then the data reported here are quite reliable. First, we
compared our GFP expression data to expression data using
SAGE to detect tissue-speciﬁc transcripts and found that
about 70% of the genes found expressed in a particular
tissue by our GFP reporter assay were also detected using
SAGE analysis. We also included in our analysis several
genes whose expression was previously characterized, either
by GFP promoter constructs or protein fusions or by
antibodies. For more than 80% of the previously charac-
terized genes we examined, the expression pattern is in
good agreement with published observations. In some cases,
we observed a wider range of expression, and in some cases,
we observed less. In less than 10% of cases, our observations
were completely at odds with what has previously been
published. Due to the possible differences in size of 59
promoter regions, differences in concatamer arrays, or even
entirely different methodologies, these discrepancies should
not be too surprising. In regard to this benchmark set of
genes, often it is not clear whether our observations are the
correct ones, or whether previous observations are correct,
or if neither reﬂect the full range of expression of the gene
in question. What we are certain of is that the annotation of
tissue and cell identity is correct in our study. We have
called upon experts within the C. elegans community and the
staff of WormAtlas in every instance in which there was a
question of cell identity. If cell identity could still not be
resolved, this was indicated in the annotation. If there are
errors, they are errors of omission, not errors of commis-
sion.
With almost 2,000 expression proﬁles, the database is an
excellent resource for examining the expression proﬁle of a
previously uncharacterized gene, even with the caveats stated
above. However, we do not feel this is the only possible use of
the data. The data reﬂect expression from less than 5 Mb of
DNA, less than 5% of the genome of this organism, and yet we
see expression in almost every tissue and cell type in the
organism. We think this is fertile ground for researchers
interested in identifying motifs regulating gene expression. In
many cases, the DNA segment regulating precise cellular and
temporal expression is considerably shorter than our
maximum size fragments of 3 kb. The ability to search this
database for short DNA sequences controlling speciﬁc
expression patterns should make it easier to identify tran-
scription factor binding sites for a particular organ, tissue, or
cell type.
Our survey of a few regions determining expression within
muscle serves as a case study. We ﬁrst identiﬁed several genes
expressed within body-wall muscle. We then picked a subset
of 59 regions and did promoter deletions in order to map
essential sites for muscle expression. Curiously, we did not
ﬁnd any single motif, but in fact, found several potential
sequences that each could direct expression in muscle
(unpublished data). The implication of these observations is
that different 59 sequences can lead to expression in the same
tissue, in this case muscle, and we suspect this multiplicity of
transcriptional control regions may occur in other tissues as
well. This adds a level of complexity to gene regulation that
many researchers fail to take into consideration. Our ﬁndings
of multiple different sequences controlling muscle expression
are similar to results reported previously [22,23], but the
sequences we have identiﬁed are different from those
reported in these earlier studies. Even though a MyoD
homolog (hlh-1) [26–28] is expressed in C. elegans muscle, it
does not seem to be the major transcription factor, because
no MyoD binding site has been found in three of four control
regions we analyzed. Recently, it has been shown that MyoD
acts as part of a trio of transcription factors to regulate
muscle differentiation in C. elegans [29].
Many of the genes in this expression database have human
orthologs, and for a number of these genes, these expression
data are the ﬁrst indication of where these genes may be
expressed in humans. We think this is an important resource
to help direct studies of these genes in mammals. Considering
the complexity of the mammalian nervous system, any gene
that we can identify in a particular subset of neurons may be
especially useful. Another use of the database has been to
conﬁrm an expression proﬁle of a speciﬁc gene identiﬁed by
other methods. Studies of adult intestine and ciliated neurons
have used the GFP strains described in this database as
conﬁrmation of tissue-speciﬁc expression of genes identiﬁed
by SAGE tags found in these tissues [30,31].
The GFP constructs described in this study are relatively
easy to make and thus lend themselves to a high-throughput
strategy. The PCR-stitching strategy we used [15] has proven
Figure 6. A Portrait of C. elegans General Tissue Expression Patterns, Driven by 59 DNA::GFP Constructs
(A) Pharynx—gene C32F10.8.
(B) Hypodermis (long arrow) and seam cell (short arrow)—gene F25H2.1 (inset: C29E4.8—embryonic hypodermis).
(C) Body wall muscle (arrow points to muscle arm)—gene F27D9.5 (inset: W01A11.1—muscle innervation).
(D) Gut—gene Y102A11A.2.
(E) Stomatointestinal muscle (long arrow) and anal depressor muscle (short arrow)—gene D1081.2.
(F) Vulval muscle (long arrow) and ventral nerve cord (short arrow)—gene Y32H12A.5.
(G) Neural (nerve ring: short arrow, ventral nerve cord: long thin arrow, and dorsal nerve cord: thick arrow)—gene C13F10.4.
(H) Excretory cell—gene F32F2.1 (inset: F48E8.3) (intersects with WormBase annotation).
doi:10.1371/journal.pbio.0050237.g006
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Gene Expression in C. elegansrobust and efﬁcient. This approach has at least one advantage
over the newly developed ‘‘promoterome’’ [12], which is that
signiﬁcantly larger 59 regions can be used for stitching when
necessary. Many regulatory regions are close to the ATG start
site, as shown for the four genes we analyzed for muscle
expression (Figure 10), but this is not always the case. A
further complication with plasmids is that they often contain
cryptic promoter elements, which one can avoid by using the
PCR-stitching approach. The use of freely segregating
concatamer arrays for this study had three implications. It
appears from a comparison of GFP expression with low tag-
frequency SAGE data that concatamer arrays of GFP may be a
sensitive tool for detecting genes with a low level of
transcription. We also demonstrated that mosaicism due to
loss of the array often led to expression in small groups of
cells or single cells, and thus allowed us to obtain a detailed
image of these cells. This has been an invaluable aid to the
WormAtlas project (http://www.wormatlas.org/). On the other
hand, an unfortunate consequence of using a concatamer
array was that it excluded us from recording germline
expression and thus monitoring the maternal contribution
to early development. Germline silencing of genes is well
documented [21], and this silencing led to us not detecting
germline expression in any of the genes we tested. It also
meant that we could not detect expression in the early
embryo (before 50 cells) in most cases.
In addition to the approaches described in this study,
other approaches to monitor gene expression will be
required if we are to monitor gene expression for the whole
genome throughout all of development. The technique of
homologous recombination in E. coli called recombineering
[32–36] is a promising approach because it allows the
modiﬁcation and manipulation of large genomic clones.
Larger DNA clones would remove some of the doubt about
whether all control elements for transcription regulation are
included. Recombineering in bacteria to construct GFP::pro-
tein fusions using fosmids with 35- to 40-kb DNA inserts
should cover all control elements for most genes in C. elegans.
Figure 7. A Portrait of C. elegans Neural Tissue Expression Patterns, Driven by 59 DNA::GFP Constructs
(A) Neural network—gene B0041.7a.
(B) Labial sensilla (arrow)—gene C17E4.5.
(C) Amphid neuron—gene T26E3.9.
(D) Ring interneuron—gene H13N06.6 (intersects with WormBase annotation).
(E) Amphid socket cells (arrow)—gene Y39D8C.1.
(F) Pre-anal (short arrow) and lumbar (long arrow) ganglion—gene C47A10.6 (intersects with WormBase annotation).
(G) Phasmid neurons—gene W01A11.2.
(H) PVT interneuron—gene M03F4.3 (intersects with WormBase annotation).
doi:10.1371/journal.pbio.0050237.g007
Figure 8. The Primordial Germ Layers’ Main Sphere of Influence: Ectoderm (Neurons and Hypodermis), Mesoderm (Muscle), and Endoderm (Intestine)
From the data, we see a fairly even distribution of expression between the germ layers: 71% of the 59 DNA sequences express in ectoderm, 63% in
endoderm, 55% in mesoderm, and about half from each germ layer contributes to the intersection of the three germ layers. Within the ectoderm (see
inset), we see that there is a preponderance of neural-specific expression (61%) relative to hypodermal-specific expression (14%). There are very few
hypodermal 59 DNA sequences that do not also express in either the nerve, muscle, or intestine.
doi:10.1371/journal.pbio.0050237.g008
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library are being used for recombineering (http://elegans.
bcgsc.bc.ca/perl/fosmid/CloneSearch) ([33] and unpublished
data). If these GFP-engineered fosmids are introduced to the
worm using a Biolistic gun [37,38], there is a higher
probability of generating a transformed animal with a single
or low copy number level of the gene. This should allow
expression in the germline and the early embryo of any gene
in which these are the normal sites of expression. Coupling
these strategies to the newer methods of lineaging early cell
division [39] should cover the stages in development over-
looked in our study.
Figure 9. A Portrait of C. elegans Reproductive Tissue Expression Patterns, Driven by 59 DNA::GFP Constructs
(A) Vulval muscles (lateral view: long arrow, ventral view: short arrow)—gene F54A5.3a (inset F33H2.3).
(B) Uterine muscles (long arrows) and body wall muscle (short arrow)—gene F10G12.5.
(C) Vulva—gene Y47G6A.7.
(D) VulA cell—gene F02D8.2. Inset shows VulA cel relative to other vulva cells.
(E) Gonad sheath cells (arrow) and gut—gene C30F12.1.
(F) Gonadal sheath cell pair 5 (arrow) and gut—gene T60A3A.9. Inset shows proximal gonadal sheath cells.
(G) Spermatheca (arrow)—gene Y43B11AR.4 (inset F40F11.2).
(H) Dorsal uterine cell (arrow)—gene C30F12.1.
(I) Distal tip cells—gene C44B12.2. Inset shows distal tip cells at end of gonad.
(J) Developing uterus—gene Y47G6A.7 (arrow indicates location of developing vulva).
doi:10.1371/journal.pbio.0050237.g009
Figure 10. Serial Deletions Series for the Promoter Regions Used To Determine the Minimal Sequence Required to Drive GFP Expression in
Muscle
(A) C34E10.6 promoter length 700–118 bp drives expression in muscle and neural tissue.
(B) F15G9.4a promoter length 2,869–326 bp drives expression in body wall muscle; at 132 bp, all expression was lost.
(C) T27A1.4 promoter length 702–157 bp drives expression only in muscle; at 53 bp, all expression was lost.
(D) T04A8.4 promoter length 2,903–995 bp drives expression in pharyngeal, vulval, and body wall muscles; promoter length 805–143 bp fails to drive
expression in pharyngeal muscle; at 55 bp, all muscle had lost expression.
doi:10.1371/journal.pbio.0050237.g010
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Identifying gene targets. Our list of target genes was based on the
4,367 C. elegans proteins identiﬁed from a comparison of C. elegans and
human predicted proteomes with InParanoid [16] (http://inparanoid.
sbc.su.se), Most of the genome annotations used in the selection of
our list of target genes were obtained from WormBase [40,41] (http://
www.wormbase.org). The list was ﬁltered to remove rRNA genes and
genes with SL2 trans-splice acceptor sites, which are associated with
operons [42,43]. Also removed were genes with characterized mRNAs,
an indication that the gene was already well studied. Preference was
given to genes with EST-conﬁrmed 59 ends and those identiﬁed as
embryonically expressed in Intronerator [44]. We kept genes for
which other researchers have constructed reporter fusions as a
control set for our study. Our ﬁnal set of targets consisted of a gene
pool enriched for, although not exclusive to, human orthologs with
unknown function.
Primer design and construction of GFP fusions. The promo-
ter::GFP fusion constructs were generated using the PCR stitching
method from Hobert [15]. The PCR experiments were designed to
capture putative 59 DNA regions by amplifying about 3 kb of genomic
DNA sequence immediately upstream of the predicted ATG initiator
site. When an upstream gene was within 3 kb, the size of the amplicon
was adjusted downward. We set the maximum primer length to be 25
nucleotides, and in order to eliminate false-positive PCR products, we
designed a nested primer immediately downstream from the most 59
primer for the second-round reaction. Where the primer encom-
passed the ATG initiator site, the G was mutated to a C, to ensure
there was only one start codon in the promoter::GFP fusion.
Early PCR experiments were designed semimanually with the aid
of primer3 [45]. To facilitate scale-up, we used Perl and AcePerl [46]
to extract C. elegans genomic DNA sequence, and annotations from
WormBase to tie them together with the primer design and validation
programs primer3 and e-PCR [47]. An interactive version of the GFP
primer design program is available at http://elegans.bcgsc.bc.ca/
promoter_primers.
We used pPD95.67 variant S65C (developed by Dr. Andrew Fire,
Carnegie Institution, http://www.addgene.org/pgvec1?f¼c&cmd¼
showcol&colid¼1) as our GFP source because it contains a GFP-
cassette and a region that has sequence overlap with the 39 primer,
thus allowing for PCR stitching. 59 DNA regions from target genes
were ampliﬁed from C. elegans N2 (Bristol) genomic DNA.
DNA ampliﬁcation mixtures consisted of Mix 1: 0.5-ll dNTP (10
mM), 1-ll N2 genomic DNA, 21.5-ll double-distilled H2O (ddH2O), 59
and 39 primers (1 ll of 12.5 lM each); and Mix 2: 0.75-ll Long Taq
(Expand Long Template PCR System made by Roche Diagnostics,
http://www.roche.com), 5-ll1 0 3Long PCR buffer (#2 from kit), 19.25-
ll ddH2O. Mix 1 and Mix 2 were combined, and PCR was carried out
for 30 cycles under the following conditions. Step 1: (1 cycle) 94 8C for
1 min. Step 2: (30 cycles) denaturation at 94 8C for 10 s, anneal at 56
8C for 30 s, and elongation at 68 8C for 2.5 min (depending on
ampliﬁcation fragment size). Step 3: 68 8C for 5.5 min. Stitched PCR
product was constructed as follows: Mix 3: 59 and 39 primers (1 llo f
12.5 lM); 0.5-ll5 9 regulatory DNA PCR product, 0.5-ll GFP PCR
product, 1.5-ll dNTP 10 mM, 21-ll ddH2O, and Mix 4: 5-ll1 0 3Long
PCR buffer, 20-ll ddH20. Mix 3 and Mix 4 were combined. PCR was
done as follows. Step 1: (1 cycle) 94 8C for 1 min. Step 2: (18 cycles)
denaturation at 94 8C for 10 s, anneal at 56 8C for 30 s, and elongation
at 68 8C for 2.5 min. Step 3: (10 cycles) 94 8C for 10 s, 56 8C for 30 s,
and 68 8C for 2.5 min (increased by 10 s each cycle). The PCR product
was stored at 4 8C.
Constructing transgenic animals containing GFP fusions. Nem-
atode strain maintenance and culture were carried out as described
by Brenner [48]. Strains were maintained at 15 8C on OP50 plates
unless otherwise speciﬁed. Strains used include dpy-5(e907) and wild-
type N2 Bristol [48].
At the beginning of the project, we injected a number of strains,
with-gel puriﬁed DNA, and came to a similar conclusion as Hobert
[15], that gel purifying DNA for injection did not signiﬁcantly change
the results.
Transgenic worms were generated by a modiﬁcation of the method
described by Mello et al. [49]. 59 regulatory DNA::GFP constructs and
dpy-5(þ) plasmid (pCeh-361) (kindly provided by C. Thacker and A.
Rose; [50]) were used to construct transgenic strains. Transformants
were identiﬁed by rescue of the dpy-5 mutant phenotype. The 59
regulatory DNA::GFP fusions were co-injected with wild-type dpy-5
plasmid DNA into P0 Dpy-5(e907) gonads using one of these systems: a
Olympus BH2-HLSK with a Leitz Westlab injection needle manipu-
lator, or a Zeiss 47 3016 microscope (Carl Zeiss, http://www.zeiss.com)
with a Leitz Westlab injection needle manipulator (http://www.leitz.
org/leitz_english/index.html), or a MINJ-7 microinjection system
with an Olympus CK40 microscope from Tritech Reseach (http://www.
tritechresearch.com). Injection mixture included ddH2O, 103TE, dpy-
5 plasmid (pCeh361, concentration 5–80 ng/ll), and 59 regulatory
DNA::GFP fusion construct (concentration 50 ng/ll). A total of 1 nl of
the ﬁnal mix (80–90 ng/ll pCeh361 and 5–20 ng/ll DNA::GFP fusion)
was microinjected into P0 worms using 1.0-mm, 6’’ ﬁlamented
capillary tubes from World Precision Instruments (http://www.
wpiinc.com) pulled on a Sutter P-97 needle puller. P0 worms were
set up for microinjection on agarose pads (2%–3% agarose ﬂattened
on cover slips) in either mineral oil (Sigma) or in halocarbon oil #700
grade (Lab Scientiﬁc, http://www.labscientiﬁc.com). An injection set
consists of 25–50 P0 worms injected with a given 59 regulatory
DNA::GFP construct. Wild-type F1s were set up individually and their
progeny were screened for wild-type animals in the F2 generation.
One or two lines yielding at least 30% wild-type progeny were
maintained as transformed stocks. For promoter analysis, DNA was
injected at 40–60 ng/ll for both subcloned constructs and PCR
fusions, using rol-6 as an injection marker.
To determine the size of the concatemeric arrays in vivo, we used
quantitative PCR to estimate the copy number of the 59 DNA::GFP
constructs and plasmids in 20 different transgenic strains. We
estimated that there were about 5–10 copies of promotor::GFP and
100–600 copies of the dpy-5 plasmid in the heritable arrays, which was
sufﬁcient for the sensitivity of our GFP assay.
We constructed chromosomal integrant strains for a subset of the
GFP constructs (1%) using a modiﬁed version of M. Koelle’s method
(http://info.med.yale.edu/mbb/koelle/). Young adult transgenic (wild-
type) P0 hermaphrodites were treated with low-dose X-ray irradiation
(1,500 R). After 1 h, the P0 animals were transferred to 90-mm OP50
plates—one P0 worm/plate for 12 plates for each strain. The P0
animals were allowed to lay eggs for 18–24 h and then were removed
in order to limit the number of F1s laid. Seven days later, mid to late
larval wild-type F2 animals were picked and set up (one/plate, 12 from
each of the 90-mm plates) at room temperature (20–22 8C). Four to 5
d later, the F2 plates were screened for the absence of Dpy-5 animals,
indicating stable inheritance of the array.
Strains intended for embryo recordings were outcrossed using an
unc-32 marker. P0 GFP-expressing hermaphrodites were crossed with
N2 males, F1 GFP males were crossed with unc-32 hermaphrodites,
and then F2 and F3 GFP hermaphrodites were individually plated.
Lastly, the F4 populations were screened for exclusively wild-type
animals. Outcrossing was done at 15 8C.
In vivo analysis and imaging of GFP-expressing animals. General
classiﬁcation and imaging of GFP expression was done initially with a
low-power GFP dissecting microscope (Zeiss stereomicroscope ﬁtted
with Kramer epiﬂuorescence), before moving to either a Zeiss
Axioplan or a Zeiss Axiophot microscope. Images were captured
using a digital camera (QICAM; QImaging, http://www.qimaging.com/
products/cameras/scientiﬁc/) and QCapture software. This was the
ﬁrst pass, where we determined the developmental stage, tissues, and,
where possible, the individual cells expressing GFP. Both stable and
unstable strains were evaluated on expression pattern complexity and
frequency of occurrence. Unusual or complicated expression
patterns, or neural expression, would undergo further analysis using
an inverted Zeiss Axiovert LSM 5 confocal microscope equipped with
epiﬂuorescence, Nomarski optics, and LSM 5 Pascal software. If we
detected pre-comma nonubiquitous expression, strains were put in
queue for stabilization and/or outcrossing, and 4-D recording and
analysis. The results of all analyses, excepting of the embryos, were
curated by hand and uploaded to the project Web site (http://gfpweb.
aecom.yu.edu/index) and WormBase (http://www.wormbase.org), and
the strains were sent to the stock centre (http://www.cbs.umn.edu/
CGC/CGChomepage.htm) and are available by request from R.
Johnsen (bjohnsen@gene.mbb.sfu.ca) (see expression pipeline in
Figure 1).
The images and movies were processed using Adobe PhotoShop 7.0
(http://www.adobe.com) and the LSM 5 Pascal volume-rendering
software. Single images were normalized and placed into image
panels before exporting to the public domain. Movies were obtained
from Z-stacks comprised of 20–60 *.lsm images, taken 0.5–1-lm
intervals apart, the speciﬁcs of which were dependant on the age of
the worm, the tissue of interest, and the intensity of the GFP. These
stacks were then optionally volume-rendered and/or converted into
QuickTime movies, normalized, and exported to the Web site.
Analysis of embryonic expression using 4-D microscopy. In some
cases, embryonic expression was determined without difﬁculty.
However, in many cases, the patterns were determined to be too
complex, and it was deemed necessary to have a 4-D recording and to
lineage the embryo. Embryos for 4-D analysis were obtained from
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transferred to a 5% agar pad and manipulated into adjacent
positions with the same orientation. Detailed expression patterns
and gene activation in the embryos were captured with live, two-
channel, four-dimensional microscopy, on a Zeiss Axioplan micro-
scope. The fourth dimension being time, Z-stacks (25 Z-images) of
developing embryos were recorded at 25 8C using Nomarski micro-
scopy every 30–45 s over a 7-h time course. Interspersed with the
normal Z-stacks, we recorded several Z-stacks of GFP ﬂuorescence in
speciﬁc cells, which were then mapped and identiﬁed relative to the
Nomarski images. Software that supports this type of microscopy
recording and analysis has been developed [19,51–53]. We used
programs derived from the study by Schnabel et al. [19] and the
program Simi Biocell to lineage the embryos [19]. The data have not
been posted to the Web site, but are available from the authors.
An interactive GFP expression Web site. All strain data are in a
mySQL database. All primer designs relative to genes and all
annotation of genes on the Web site are based on WormBase version
140. The functionality of the Web site is based on perl/CGI and perl
modules for the queries, which provide the user with three formats
for accessing the data: (1) the display of all strains and data for
browsing, (2) the selection of speciﬁc genes and the information the
user wants to see for each gene, and (3) a gene search, based on tissue
expression pattern. All of the data can be downloaded in .tab or .csv
format from WormAtlas (http://gfpweb.aecom.yu.edu/index). The data
are also available at WormBase (http://www.wormbase.org).
Supporting Information
Figure S1. Comparison of Biological Process GO Annotation between
the GFP Gene Set and across the Whole Genome
Found at doi:10.1371/journal.pbio.0050237.sg001 (1.0 MB TIF).
Table S1. A Subset of Our Positive Controls Compared with Prior
Expression Annotations in WormBase
The annotations for the positive controls in both our dataset and
WormBase were manually compared to determine the degree to
which our results intersected with other labs. The primary techniques
listed in WormBase were both transcriptional and translational GFP
fusions, LacZ reporters, and antibody staining.
Found at doi:10.1371/journal.pbio.0050237.st001 (54 KB DOC).
Table S2. Conﬁrmation of 59 DNA::GFP Fusion Sensitivity in C. elegans
by Comparison with Single SAGE Tags
There are 232 single-tag genes for which we detect a GFP signal.
Found at doi:10.1371/journal.pbio.0050237.st002 (111 KB DOC).
Table S3. Primers Used in PCR Fusion Constructs for Promoter
Analysis of Muscle-Expressing 59 DNA Sequences
Found at doi:10.1371/journal.pbio.0050237.st003 (80 KB DOC).
Video S1. C. elegans H13N06.6 Promoter::GFP Expression (a Gene
Related to Norepinephrine Deﬁciency in Humans) in the Gonad
Sheath Cells, Spermatheca, and Uterus of the Adult Worm
Found at doi:10.1371/journal.pbio.0050237.sv001 (2.1 MB MOV).
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